Why a book dedicated to rare cancer management? Given the large variety of rare cancers, they take up a significant part of our daily practice. Therefore, we owe it to our patients with rare tumours that we use the knowledge gained in the treatment of the more common cancers to …
Explique le plus simplement possible le cancer : ses origines, les facteurs déclencheurs et les perspectives de traitement.
Que sait-on du cancer?
by Delehedde, Maryse, Denhez, Frédéric
fromCollection Bulles de sciences
Explique le plus simplement possible le cancer : ses origines, les facteurs déclencheurs et les perspectives de traitement.
Explique le plus simplement possible le cancer : ses origines, les facteurs déclencheurs et les perspectives de traitement.
It is difficult to overstate the potential applications of stem-cell biology to our understanding of, and responses to, disease and injury. This volume aims to bring to its readers authoritative and responsive coverage of aspects of the field that will keep them up-to-date in a …
It is difficult to overstate the potential applications of stem-cell biology to our understanding of, and responses to, disease and injury. This volume aims to bring to its readers authoritative and responsive coverage of aspects of the field that will keep them up-to-date in a …
Explains various methods used to diagnose different types of cancer, and discusses the process of deciding a course for treatment.
Explains various methods used to diagnose different types of cancer, and discusses the process of deciding a course for treatment.
The epidermal growth factor (EGF) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGFR therapies. Edited by John Haley a…
The epidermal growth factor (EGF) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGFR therapies. Edited by John Haley a…